111 related articles for article (PubMed ID: 29871820)
1. Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study.
Culié D; Garrel R; Viotti J; Schiappa R; Chamorey E; Fakhry N; Lallemant B; Vergez S; Dupret-Bories A; Dassonville O; Poissonnet G; Santini J; Peyrade F; Benezery K; Sudaka A; Jourdan-Soulier F; Chapel F; Guelfucci B; Bozec A
Eur J Surg Oncol; 2018 Dec; 44(12):1908-1913. PubMed ID: 29871820
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
3. Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study.
Culié D; Viotti J; Modesto A; Schiappa R; Chamorey E; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Ramay AS; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Bozec A
Eur J Surg Oncol; 2021 Feb; 47(2):367-374. PubMed ID: 33004271
[TBL] [Abstract][Full Text] [Related]
4. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
Oral Oncol; 2021 Jan; 112():105041. PubMed ID: 33129057
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.
Raman A; Sen N; Ritz E; Fidler MJ; Revenaugh P; Stenson K; Al-Khudari S
Am J Otolaryngol; 2019; 40(5):626-630. PubMed ID: 31174931
[TBL] [Abstract][Full Text] [Related]
6. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality?
Fischer CA; Zlobec I; Green E; Probst S; Storck C; Lugli A; Tornillo L; Wolfensberger M; Terracciano LM
Int J Cancer; 2010 Mar; 126(5):1256-62. PubMed ID: 19697324
[TBL] [Abstract][Full Text] [Related]
7. Association of Extracapsular Spread With Survival According to Human Papillomavirus Status in Oropharynx Squamous Cell Carcinoma and Carcinoma of Unknown Primary Site.
Kharytaniuk N; Molony P; Boyle S; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):683-690. PubMed ID: 27196434
[TBL] [Abstract][Full Text] [Related]
8. Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.
Huang YH; Yeh CH; Cheng NM; Lin CY; Wang HM; Ko SF; Toh CH; Yen TC; Liao CT; Ng SH
PLoS One; 2017; 12(7):e0180779. PubMed ID: 28686646
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
[TBL] [Abstract][Full Text] [Related]
11. Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
Oral Oncol; 2021 Nov; 122():105503. PubMed ID: 34500315
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
13. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
[TBL] [Abstract][Full Text] [Related]
14. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
15. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
17. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH
Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
[TBL] [Abstract][Full Text] [Related]
19. Robust Differences in p16-Dependent Oropharyngeal Squamous Cell Carcinoma Distant Metastasis: Implications for Targeted Therapy.
Jaber JJ; Murrill L; Clark JI; Johnson JT; Feustel PJ; Mehta V
Otolaryngol Head Neck Surg; 2015 Aug; 153(2):209-17. PubMed ID: 25917669
[TBL] [Abstract][Full Text] [Related]
20. Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study.
Culié D; Schiappa R; Modesto A; Viotti J; Chamorey E; Dassonville O; Poissonnet G; Bizeau A; Vergez S; Dupret-Bories A; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Ramay AS; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Mirghani H; Gorphe P; Guelfucci B; Garrel R; Temam S; Bozec A
Eur J Surg Oncol; 2021 Jun; 47(6):1389-1397. PubMed ID: 33390333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
